Arsenic trioxide and acute promyelocytic leukemia:: Clinical and biological

被引：0
|
作者：
Chen, Z.
Zhao, W-L.
Shen, Z-X.
Li, J-M.
Chen, S-J.
Zhu, J.
Lallemand-Breittenbach, V.
Zhou, J.
Guillemin, M-C.
Vitoux, D.
de The, H.
机构：
[1] Shanghai Jiao Tong Univ, Shanghai Inst Hematol, Rui Jin Hosp, Sch Med, Shanghai 200025, Peoples R China
[2] Hop St Louis, CNRS, UMR 7151, Hop St Louis, F-75475 Paris, France
来源：
ACUTE PROMYELOCYTIC LEUKEMIA: MOLECULAR GENETICS, MOUSE MODELS AND TARGETED THERAPY | 2007年 / 313卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Arsenic has recently been identified as an effective drug in the treatment of newly diagnosed and relapsed acute promyelocytic leukemia. Indeed, arsenic trioxide combined with all-trans retinoic acid shows a synergistic effect. Mechanistically, arsenic targets the key leukemogenic protein PML-RAR alpha, setting up a new example of molecular target-based cancer therapy.
引用
收藏
页码：129 / 144
页数：16
相关论文
共 50 条
  • [31] Arsenic trioxide in the treatment of relapsed and refractory acute promyelocytic leukemia
    Asou, N
    INTERNAL MEDICINE, 2005, 44 (08) : 775 - 776
  • [32] Pharmacokinetics of intravenous arsenic trioxide in the treatment of acute promyelocytic leukemia
    倪建华
    陈国强
    沈志祥
    李秀松
    刘海卫
    黄燕婷
    方智雯
    陈赛娟
    王振义
    陈竺
    Chinese Medical Journal, 1998, (12)
  • [33] ATRA/ARSENIC TRIOXIDE THERAPY FOR CHILDREN WITH ACUTE PROMYELOCYTIC LEUKEMIA
    Minato, Sonoko
    Gocho, Yoshihiro
    Sakaguchi, Hirotoshi
    Iguchi, Akihiro
    Deguchi, Takao
    Ohki, Kentarou
    Kiyokawa, Takanobu
    Matsumoto, Kimikazu
    Tomizawa, Daisuke
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [34] Visual Hallucinations With Arsenic Trioxide Therapy in Acute Promyelocytic Leukemia
    Mahadevia, Himil J.
    Al-Obaidi, Ammar
    Cossor, Furha
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [35] Pharmacokinetics of arsenic trioxide in patients with acute promyelocytic leukemia.
    Nagy, AJ
    Wang, ZG
    Maslak, P
    Chanel, S
    Ho, R
    Spriggs, D
    Tong, W
    Ellison, R
    Pandolfi, PP
    Warrell, RP
    Soignet, SL
    JOURNAL OF INVESTIGATIVE MEDICINE, 1999, 47 (02) : 100A - 100A
  • [36] Arsenic trioxide for acute promyelocytic leukemia in a patient on chronic hemodialysis
    Tinajero, Jose
    El-Shami, Khaled
    Wu, Xiaojun
    Smith, B. Douglas
    Newman, Matthew J.
    LEUKEMIA RESEARCH REPORTS, 2022, 17
  • [37] Pharmacokinetics of intravenous arsenic trioxide in the treatment of acute promyelocytic leukemia
    Ni, JH
    Chen, GQ
    Shen, ZX
    Li, XS
    Liu, HW
    Huang, YT
    Fang, ZW
    Chen, SJK
    Wang, ZY
    Chen, Z
    CHINESE MEDICAL JOURNAL, 1998, 111 (12) : 1107 - 1110
  • [38] Arsenic trioxide:: a "successful poison" in patients with acute promyelocytic leukemia
    Lengfelder, E.
    Schultheis, B.
    Buechner, T.
    Hehlmann, R.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2007, 132 (07) : 330 - 336
  • [39] METABOLIC CHARACTERIZATION OF ACUTE PROMYELOCYTIC LEUKEMIA AND ARSENIC TRIOXIDE RESISTANCE
    Noguera, N. I.
    Banella, C.
    Catalano, G.
    Ammatuna, E.
    Pelosi, E.
    Faraoni, I.
    Divona, M.
    Otone, T.
    Lavorgna, S.
    Testa, U.
    Arcese, W.
    Voso, M. T.
    HAEMATOLOGICA, 2020, 105 : S84 - S84
  • [40] Summary report on the treatment of acute promyelocytic leukemia with arsenic trioxide
    Jin, H
    Li, XQ
    Li, HY
    METAL IONS IN BIOLOGY AND MEDICINE, VOL 8, 2004, 8 : 543 - 547
12345